Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-408
Closed -$33K 111
2019
Q3
$33K Hold
408
0.02% 65
2019
Q2
$33K Hold
408
0.02% 66
2019
Q1
$32K Hold
408
0.02% 70
2018
Q4
$30K Hold
408
0.02% 61
2018
Q3
$28K Hold
408
0.02% 66
2018
Q2
$24K Hold
408
0.02% 78
2018
Q1
$21K Hold
408
0.02% 81
2017
Q4
$22K Hold
408
0.02% 71
2017
Q3
$25K Sell
408
-63
-13% -$3.82K 0.02% 64
2017
Q2
$29K Hold
471
0.02% 56
2017
Q1
$29K Hold
471
0.02% 53
2016
Q4
$26K Hold
471
0.02% 59
2016
Q3
$28K Buy
+471
New +$27.5K 0.02% 53

Other funds holding MRK

C-J Advisory's MRK Position: Q4 2019 in Review

C-J Advisory sold out of Merck (MRK) in Q4 2019, closing a stake of 408 shares — an estimated $33K sold.

C-J Advisory first reported a position in MRK in Q3 2016 and held it in 13 quarters. The position peaked at $33K in Q3 2019. 2,536 funds tracked by Wall St. Rank hold MRK as of Q4 2019.

  • C-J Advisory reported no remaining Merck position as of Q4 2019 after selling out during the quarter.
  • C-J Advisory sold 408 Merck shares in Q4 2019, an estimated $33K.
  • C-J Advisory first reported a position in Merck in Q3 2016 and held it in 13 quarters.
  • C-J Advisory's Merck position peaked at $33K in Q3 2019.
  • 2,536 funds tracked by Wall St. Rank held Merck as of Q4 2019.

Based on C-J Advisory's 13F filing for Q4 2019, filed 10 Feb 2020.